Abstract：Objective: To study the effects of ELF5 gene on cycles and apoptosis of human endometria cancer cells and its probable mechanism. Methods: The eukaryotic expression vectedical or pcDNA3.1-ELF5+EGFP was transfected into human endometria cancer cells in vitro (recombinant plasmid group), and positive cell clones were selected by G418 and amplified. Transfected pcDNA3.1-EGFP cells (empty plasmid group) and untransfected cells (blank control group) were served as control groups. In vitro, the cell prolifetraion ability of three groups was analyzed by MTT; the cycle and apoptosis was analyzed by flow cytometry; the expression of protein P21 and Caspase-3 was detected by Western blot. In vivo, three groups of cells were transplanted into NOD/SCID nude mice, and observed the growth ability of tumors; the apoptosis of tumors was determined by TUNEL; the expression of protein P21 and Caspase-3 in tumors was detected by Western blot. Results: The recombinant plasmid pcDNA3.1- ELF5+EGFP was successfully transfected into human endometria cancer cells; The expression of ELF5 mRNA in the recombinant plasmid group was higher than that in the empty plasmid group and blank control group (P<0.05); At each time point, the cell proliferation ability of the recombinant plasmid group was significantly decreased than that of the empty plasmid group and blank control group, the differences were statistically significant (P<0.05); The number of cells arrested in G0/G1 phase of the recombinant plasmid group was higher than that of the empty plasmid group and blank control group, the differences were statistically significant (P<0.05); The apoptosis rate of the recombinant plasmid group was compared with the empty plasmid group and the blank control group, the differences were statistically significant (P<0.05); The expression of protein P21 and Caspase-3 in the recombinant plasmid group was higher than that in the empty plasmid group and blank control group (P<0.05). In vivo, the growth ability of tumors (maximum diameter, weight) in recombinant plasmid group was lower than that in the empty plasmid group and blank control group, the differences were statistically significant (P<0.05); In vivo, the apoptosis rate of the recombinant plasmid group was compared with the empty plasmid group and the blank control group, the differences were statistically significant (P<0.05); In vivo, the expression of protein P21 and Caspase-3 in the recombinant plasmid group was higher than that in the empty plasmid group and blank control group (P<0.05). Conclusions: ELF5 gene has obvious effects on cycles and apoptosis of human endometria cancer cells and its mechanism connected with the protein P21 and Caspase-3.
戚挺, 踪佳鹏, 闫洪超. 转染ELF5mRNA对子宫内膜癌细胞凋亡及周期的影响[J]. 河北医学, 2017, 23(6): 889-894.
QI Ting, et al. Effect of Transfection of ELF5 mRNA on Apoptosis and Cycle of Endometrial Carcinoma Cells. 河北医学, 2017, 23(6): 889-894.
[1] Gu HQ,Zhang ZB,et al. The role of the SDF-1/CXCR7 axis on the growth and invasion ability of endometrial cancer cells[J].Arch Gynecol Obstet,2017,17:4308.
[2] Chou WC,Lee PH,Tan YY,et al.An integrative transcriptomic analysis revealsbisphenol A exposure-induced dysregulation of microRNA expression inhuman endometrial cells[J].Toxicol in Vitro,2017, 2:12.
[3] Frend HT, Watson CJ.ELF5-breast cancer's little helper[J].Breast Cancer Res,2013,15(2):307.
[4] 钱卫卫,闫洪超.ELF5mRNA在卵巢上皮性癌组织中的表达及临床意义[J].中国煤炭工业医学杂志,18(12):2009~2012.
[5] 仇影影,谢肖磊等.转染ELF5基因的人卵巢癌干细胞增殖、侵袭能力及凋亡变化[J].山东医药,2016,56(19):25~27.
[6] Yang S, Thiel KW, Leslie KK. Progesterone: the ultimate endometrial tumor suppressor[J].Trends Endocrinol Metab, 2011, 22(4): 145~152.
[7] Arem H, Park Y, Pelser C, et al.Prediagnosis body mass index, physical activity and mortality in endometrial cancer patients[J].Jnci Natl Cancer Inst, 2013, 105 (5) : 342~349.
2017, Vol. 23 
冀公网安备13080202000677号